Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Orient: Consumption may usher in a turning point in the second half of 2026, with significant differentiation in fundamental performance.
Lei Dao L80 pre-sale orders exceeded the same period as last year's L90, with Nio Hong Kong stocks leading the rise in the Hang Seng Technology Index.
HK Stock Market Move | JIANGXI COPPER (00358) rose over 4% in the afternoon, with a year-on-year increase of more than 40% in net profit attributable to mother in the first quarter. Citi expects the smelting business to remain profitable.
Orient: Consumption may usher in a turning point in the second half of 2026, with significant differentiation in fundamental performance.
Lei Dao L80 pre-sale orders exceeded the same period as last year's L90, with Nio Hong Kong stocks leading the rise in the Hang Seng Technology Index.
HK Stock Market Move | JIANGXI COPPER (00358) rose over 4% in the afternoon, with a year-on-year increase of more than 40% in net profit attributable to mother in the first quarter. Citi expects the smelting business to remain profitable.
